ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

GUD Knight Therapeutics Inc

5.70
-0.04 (-0.70%)
14 Jun 2024 - Closed
Delayed by 15 minutes

Knight Therapeutics Financial Summary

The current GUD market cap is 576.67M. The company's latest EPS is CAD -0.1664 and P/E is -34.25.

Year End 31 December 2023 20192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Revenue 49.66M199.69M243.61M297.59M331.1M
Operating Income -13.78M-30.49M-12.7M-13.04M15k
Net Income 18.03M42.07M15.68M-29.89M-16.84M
Year End 31 December 2023 20192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Assets 1.31B1.04B991.89M1.05B945.49M
Total Liabilities 390.2M153.44M149.87M228.98M198.62M
Total Equity 915.11M886.24M842.02M825.86M746.87M

Cash Flow

Year End 31 December 2023 20192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Operating 4.6M-12.21M44.62M40.48M35.94M
Investing -11.86M101.35M-105.28M-63.08M29.34M
Financing -62.8M-29.23M-78.31M1.76M-81M
Market Cap 576.67M
Price to Earnings Ratio -34.25
Price to Sales Ratio 1.74
Price to Cash Ratio 9.81
Price to Book Ratio 0.77
Dividend Yield -

Share Statistics

Shares Outstanding 101.17M
Average Volume (1 week) 54.54k
Average Volume (1 Month) 65.46k
52 Week Change 15.62%
52 Week High 6.22
52 Week Low 4.35
Spread (Intraday) 0.01 (0.18%)

Company Info

Company Name Knight Therapeutics Inc
Address 3400 de maisonneuve w
montreal, quebec H3Z 3B8
Website https://www.gudknight.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock